Alkermes plc. (ALKS) stock
ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30213% above fair value
$47.89+1.42 (+3.06%)
Close on Nov 11, 2026Market cap $8.03BP/E 126.0Yield –
Alkermes profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Alkermes's profit margin for the twelve months ending Jun 30, 2026 was 4.0%. For fiscal 2025 it was 16.4%, against 23.6% the year before. The highest annual figure on record is 23.6% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 16.4% | −7.2 |
| FY2024 | Dec 31, 2024 | 23.6% | +2.2 |
| FY2023 | Dec 31, 2023 | 21.4% | +35.6 |
| FY2022 | Dec 31, 2022 | -14.2% | −10.1 |
| FY2021 | Dec 31, 2021 | -4.1% | +6.6 |
| FY2020 | Dec 31, 2020 | -10.7% | +6.1 |
| FY2019 | Dec 31, 2019 | -16.8% | −4.1 |
| FY2018 | Dec 31, 2018 | -12.7% | +4.8 |
| FY2017 | Dec 31, 2017 | -17.5% | +10.5 |
| FY2016 | Dec 31, 2016 | -28.0% | +8.2 |
| FY2015 | Dec 31, 2015 | -36.2% | −40.5 |
| FY2013 | Mar 31, 2013 | 4.3% | +33.5 |
| FY2012 | Mar 31, 2012 | -29.1% | −4.8 |
| FY2011 | Mar 31, 2011 | -24.4% | −2.2 |
| FY2010 | Mar 31, 2010 | -22.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 0.1% | −22.2 |
| Q1 FY2026 | Mar 31, 2026 | -16.9% | −24.2 |
| Q4 FY2025 | Dec 31, 2025 | 12.8% | −21.2 |
| Q3 FY2025 | Sep 30, 2025 | 21.0% | −3.4 |
| Q2 FY2025 | Jun 30, 2025 | 22.3% | −0.6 |
| Q1 FY2025 | Mar 31, 2025 | 7.3% | −3.2 |
| Q4 FY2024 | Dec 31, 2024 | 34.1% | +4.2 |
| Q3 FY2024 | Sep 30, 2024 | 24.4% | +11.9 |
| Q2 FY2024 | Jun 30, 2024 | 22.9% | −15.5 |
| Q1 FY2024 | Mar 31, 2024 | 10.5% | +25.1 |
| Q4 FY2023 | Dec 31, 2023 | 29.9% | +39.2 |
| Q3 FY2023 | Sep 30, 2023 | 12.5% | +37.9 |
| Q2 FY2023 | Jun 30, 2023 | 38.4% | +49.3 |
| Q1 FY2023 | Mar 31, 2023 | -14.5% | −1.7 |
| Q4 FY2022 | Dec 31, 2022 | -9.3% | −9.5 |
| Q3 FY2022 | Sep 30, 2022 | -25.4% | −15.5 |
| Q2 FY2022 | Jun 30, 2022 | -10.9% | −11.7 |
| Q1 FY2022 | Mar 31, 2022 | -12.9% | −4.0 |
| Q4 FY2021 | Dec 31, 2021 | 0.3% | +15.5 |
| Q3 FY2021 | Sep 30, 2021 | -9.9% | −9.8 |
| Q2 FY2021 | Jun 30, 2021 | 0.8% | +12.7 |
| Q1 FY2021 | Mar 31, 2021 | -8.9% | +6.8 |
| Q4 FY2020 | Dec 31, 2020 | -15.2% | −13.9 |
| Q3 FY2020 | Sep 30, 2020 | -0.1% | +20.7 |
| Q2 FY2020 | Jun 30, 2020 | -11.9% | +3.1 |
| Q1 FY2020 | Mar 31, 2020 | -15.7% | +27.5 |
| Q4 FY2019 | Dec 31, 2019 | -1.3% | +1.8 |
| Q3 FY2019 | Sep 30, 2019 | -20.7% | −6.9 |
| Q2 FY2019 | Jun 30, 2019 | -15.0% | −4.3 |
| Q1 FY2019 | Mar 31, 2019 | -43.2% | −15.4 |
| Q4 FY2018 | Dec 31, 2018 | -3.1% | – |
| Q3 FY2018 | Sep 30, 2018 | -13.8% | – |
| Q2 FY2018 | Jun 30, 2018 | -10.7% | – |
| Q1 FY2018 | Mar 31, 2018 | -27.8% | – |
See a number that looks wrong?